Sutro Biopharma (STRO) Return on Sales (2017 - 2026)
Sutro Biopharma (STRO) posted Return on Sales of 0.07% for Q4 2025, down 20.77% sequentially from 0.06% in Q3 2025, and down 2.0% YoY from 0.07% in Q4 2024.
Sutro Biopharma (STRO) Return on Sales (2017 - 2026) Analysis & Trends
Sutro Biopharma has reported Return on Sales for 9 years, with the latest figure at 0.07% in Q4 2025.
- Quarterly Return on Sales fell 2.0% year-over-year to 0.07% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.02% (up 2.0% YoY) and the FY2025 annual result came in at 0.02%, up 2.0% from the prior year.
- Return on Sales eased to 0.07% in Q4 2025 per STRO's latest filing, from 0.06% in the prior quarter.
- Over five years, Return on Sales peaked at 0.0% in Q4 2023 and troughed at 0.07% in Q4 2025.
- A 5-year average of 0.03% and a median of 0.04% in 2021 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2022 and 2023: Return on Sales decreased 5 bps in 2022, then grew 4 bps in 2023.
- Over 5 years, Return on Sales stood at 0.04% in 2021, then declined by 12 bps to 0.04% in 2022, then jumped by 107 bps to 0.0% in 2023, then slumped by 1891 bps to 0.05% in 2024, then sank by 45 bps to 0.07% in 2025.
- According to Business Quant data, Return on Sales over the past three periods registered 0.07%, 0.06%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Sutro Biopharma | 339.58 Mn | 175.24 Mn | - | -0.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.04% |
| Dec 31, 2025 | -0.07% |
| Sep 30, 2025 | -0.06% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | -0.06% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.04% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.07% |
| Dec 31, 2021 | -0.04% |
| Sep 30, 2021 | -0.04% |
| Jun 30, 2021 | 0.00% |